Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.
Shi, Xiaoli
Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells. [electronic resource] - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Dec 2017 - 1186-1192 p. digital
Publication Type: Journal Article
1950-6007
10.1016/j.biopha.2017.11.100 doi
Antineoplastic Agents, Phytogenic--pharmacology
Apoptosis--drug effects
Carcinoma, Squamous Cell--drug therapy
Cell Cycle Checkpoints--drug effects
Cell Line, Tumor
Dihydropyridines--pharmacology
Drug Resistance--drug effects
Esophageal Neoplasms--drug therapy
G2 Phase Cell Cycle Checkpoints--drug effects
Humans
Paclitaxel--pharmacology
Proto-Oncogene Proteins c-bcl-2--metabolism
Reactive Oxygen Species--metabolism
Small Molecule Libraries--pharmacology
Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells. [electronic resource] - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Dec 2017 - 1186-1192 p. digital
Publication Type: Journal Article
1950-6007
10.1016/j.biopha.2017.11.100 doi
Antineoplastic Agents, Phytogenic--pharmacology
Apoptosis--drug effects
Carcinoma, Squamous Cell--drug therapy
Cell Cycle Checkpoints--drug effects
Cell Line, Tumor
Dihydropyridines--pharmacology
Drug Resistance--drug effects
Esophageal Neoplasms--drug therapy
G2 Phase Cell Cycle Checkpoints--drug effects
Humans
Paclitaxel--pharmacology
Proto-Oncogene Proteins c-bcl-2--metabolism
Reactive Oxygen Species--metabolism
Small Molecule Libraries--pharmacology